Blog One Patient, One Vaccine: Inside the First NeoVax Ovarian Cancer TrialBy Alba MartinOctober 16, 2026 NeoVax, a vaccine built from each patient’s own tumour mutations, passed an early feasibility and safety test with nivolumab in recurrent ovarian cancer.